Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Power List / 2025

The Power List 2025

csm_0425-402_Feature_-_PL_In_Article_59c86b0a67.webp

Amplifying the innovators of tomorrow – today

Innovation in pharma isn’t just about molecules and machinery; it’s powered by people. Visionaries, disruptors, and dedicated minds drive the next wave of medicine, transforming bold ideas into life-changing therapies for patients around the world.

Once again, The Medicine Maker community answered the call to spotlight those shaping the future of drug development. Through your nominations, we’ve curated this year’s Power List: 30 standout pioneers accelerating progress across drug development in traditional small molecules, biologics, and advanced therapies.

In a world defined by rapid change, unprecedented challenges, and incredible new scientific advances, these trailblazers don’t just adapt – they lead through their influence to ignite innovation, inspire action, and push boundaries. Welcome to the 2025 Power List: a celebration of the minds moving medicine forward.

Advanced Medicine

Alan Boyd
Alan Boyd

CEO and Founder, Boyds

Daria Donati
Daria Donati

Chief Scientific Officer of Genomic Medicine, Cytiva

Miguel Forte
Miguel Forte

President, ISCT and CEO, Kiji Therapeutics

Fabian Gerlinghaus
Fabian Gerlinghaus

CEO and Co-Founder, Cellares

Audrey Greenberg
Audrey Greenberg

Founder and CEO, AG Capital Advisors

John Maher
John Maher

Founder and Chief Scientific Officer, Leucid Bio

Samir Ounzain
Samir Ounzain

CEO and Co-founder, HAYA Therapeutics

Jonathan Rigby
Jonathan Rigby

CEO, Sernova Biotherapeutics

Stella Vnook
Stella Vnook

CEO, Likarda

Claudia Zylberberg
Claudia Zylberberg

Board Chair and Co-Founder, Kosten Digital; Board Chair and Co-Founder, Arscience Biotherapeutics; Foundation Board Member, Alliance for mRNA Medicines; Chair of the Board at Akron Bio

Biopharma

Hesham A. Abdullah
Hesham A. Abdullah

Senior Vice President and Global Head of Oncology Research and Development, GSK

Charlotte Allerton
Charlotte Allerton

Head of Preclinical and Translational Sciences, Pfizer

Jayasree K. Iyer
Jayasree K. Iyer

CEO, Access to Medicine Foundation

Maik Jornitz
Maik Jornitz

Principal Consultant, BioProcess Resources LLC

Beatrice (Bea) Lavery
Beatrice (Bea) Lavery

Vice President and Regulatory Strategy Senior Leader, Genentech, a member of the Roche Group

Hanns-Christian Mahler
Hanns-Christian Mahler

CEO (Chief Enablement Officer) & Board Member, ten23 health

Kiran Mazumdar-Shaw
Kiran Mazumdar-Shaw

Group Chairperson, Biocon Group

Niven Narain
Niven Narain

President and CEO, BPGbio

John V. Oyler
John V. Oyler

Co-Founder, Chairman, and CEO, BeiGene

Mike Rea
Mike Rea

CEO, IDEA Pharma

Small Molecules

Christine Allen
Christine Allen

Professor, University of Toronto; Co-founder and CEO, Intrepid Labs

Jeremy Bender
Jeremy Bender

CEO, Day One Biopharmaceuticals

Lawrence Blatt
Lawrence Blatt

Chairman, President, and CEO, Aligos Therapeutics

Ann Cleves
Ann Cleves

VP of Application Science, BioPharmics Division, Optibrium

Lee Cronin
Lee Cronin

Founder and CEO, Chemify; Regius Professor of Chemistry, University of Glasgow, UK

Faye Feller
Faye Feller

Executive Vice President and Chief Medical Officer, Geron

Edward Hæggström
Edward Hæggström

CEO, Nanoform

Kevin Kreutter
Kevin Kreutter

Senior Vice President, Drug Discovery, Empress Therapeutics

Tara Rheault
Tara Rheault

Chief Development Officer, Verona Pharma

Ali Tavassoli
Ali Tavassoli

CSO and Co-Founder, Curve Therapeutics; Professor of Chemical Biology, University of Southampton, UK

Recommended

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.